Ohnishi Kazunori | Department Of Internal Medicine Hamamatsu University School Of Medicine
スポンサーリンク
概要
- OHNISHI Kazunoriの詳細を見る
- 同名の論文著者
- Department Of Internal Medicine Hamamatsu University School Of Medicineの論文著者
関連著者
-
OHSHIMA Koichi
Department of Pathology, Kurume University School of Medicine
-
OHASHI Kazuteru
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
AKIYAMA Hideki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
SAKAMAKI Hisashi
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
SUZUMIYA Junji
Department of Internal Medicine, Fukuoka University Chikushi Hospital
-
Kikuchi M
Department Of Pathology School Of Medicine Fukuoka University
-
KIKUCHI Masahiro
Department of Pathology, School of Medicine, Fukuoka University
-
三木 義男
癌研ゲノムセンター
-
YOSHINO Tadashi
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutica
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Sadahira Yoshito
Department Of Pathology School Of Medicine Kurume University
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
Nakamura S
Department Of Pathology Nagoya University School Of Medicine
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Satoh Hiroshi
Department of Pharmacy, Niigata University Medical and Dental Hospital
-
SUGITA Yasuo
Department of Pathology and Biodefense, Saga University, Faculty of Medicine
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Hirose Shinichi
Department of Pediatrics, Faculty of Medicine, Fukuoka University
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
Nakamura Shigeo
国立がんセンター中央病院 血液内科
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
OHNO Ryuzo
Aichi Cancer Center
-
YOSHIDA Shiro
Department of Obstetrics, Center for Perinatal Medicine
-
Yoshida Shiro
Department Of Obstetrics Center For Perinatal Medicine
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
渋谷 博孝
福山大学
-
下田 博司
森下仁丹株式会社商品開発本部
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
KAKIHANA Kazuhiko
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
FUJISAKI Tomoaki
Department of Internal Medicine, Matsuyama Red Cross Hospital
-
ETO Tetsuya
Department of Hematology, Hamanomachi Hospital
-
MORIUCHI Yukiyoshi
Department of Hematology, Sasebo City General Hospital
-
UTSUNOMIYA Atae
Department of Hematology, Imamura Bun-in Hospital
-
ABE Yasunobu
Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu Univers
-
永井 正
自治医科大学内科学講座血液学部門
-
谷脇 雅文
高知工科大学工学部
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Horlad Hasita
Department Of Gastroenterological Surgery Graduate School Of Medical Sciences Kumamoto University
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
CHOU Takaaki
Department of Internal Medicine, Niigata Cancer Center Hospital
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
KOJIMA Masaru
Department of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine
-
永井 正
自治医科大学 内科学講座血液学部門
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
YAMAGUCHI Toshikazu
Development of Clinical Genomics, BML
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
KIYOI Hitoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
NAGAI Tadashi
Division of Hematology, Jichi Medical University
-
TAKEUCHI Jin
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
SEKI Ritsuko
Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine
-
KAWANO Fumio
Department of Internal Medicine, National Hospital Organization, Kumamoto Medical Center
-
GONDO Hisashi
Department of Internal Medicine, Saga Prefectural Hospital Koseikan
-
MAKINO Shigeyoshi
Department of Internal Medicine, Miyazaki Prefectural Hospital
-
TAGUCHI Fumihiro
Department of Hematology, Iizuka Hospital
-
KAMIMURA Tomohiko
Department of Hematology, Harasanshin General Hospital
-
TSUDA Hiroyuki
Division of Clinical Hematology, Kumamoto City Hospital
-
OGAWA Ryosuke
Shimonoseki City Central Hospital
-
SHIMODA Kazuya
Department of Internal Medicine, Gastroenterology and Hematology, Faculty of Medicine, Miyazaki Univ
-
YAMASHITA Kiyoshi
Department of Internal Medicine, Gastroenterology and Hematology, Faculty of Medicine, Miyazaki Univ
-
SUZUKI Keiko
Department of Internal Medicine, Koga General Hospital
-
SUZUSHIMA Hitoshi
Department of Internal Medicine, NTT Nishinippon Kyushu General Hospital
-
TSUKAZAKI Kunihiro
Molecular Medicine Unit and Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate
-
HIGUCHI Masakazu
Department of Internal Medicine, Kyushu Kosei-nenkin Hospital
-
IWAHASHI Masahiro
Department of Internal Medicine, Saiseikai-Hita Hospital
-
IMAMURA Yutaka
Department of Hematology, St. Mary Hospital
-
TAMURA Kazuo
Division of Medical Oncology and Hematology, Department of Medicine, Fukuoka University Hospital
-
YOSHIDA Minoru
Japanese Red Cross Kumamoto Health Care Center
-
MATSUMOTO Tadashi
Department of Hematology, Imamura Hon-in Hospital
-
OKAMURA Takashi
Division of Hematology, Department of Medicine, Kurume University School of Medicine
-
Tamura Kazuo
First Department of Internal Medicine, Fukuoka University
-
山田 幸子
日本大学医学部生化学分野
-
Takeya Motohiro
Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University
-
梶原 哲郎
Tochigi Cancer Center Hospital
-
梶原 哲郎
東京女子医科大学第二病院外科
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
Nakamura Yusuke
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of T
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Miyamoto Toshihiro
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
山田 静雄
静岡県立大学薬学部
-
山田 静雄
横浜薬科大学 薬理学研究室
-
KATAGIRI Toyomasa
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, the University
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
Katagiri Toyomasa
京都大学 医学部外科学
-
Katagiri T
Univ. Tokyo Tokyo Jpn
-
Katagiri Toyomasa
Laboratory Of Molecular Biosignal Research Center Kobe University School Of Medicine
-
Nagane Yutaka
Department Of Urology Sanai Hospital
-
Kajiwara Tetsuro
Tochigi Cancer Center Hospital
-
Kodama Tetsuro
栃木県立がんセンター研究所 がん遺伝子研究室
-
Kasugai Tsutomu
東京大学医科学研究所ヒトゲノム解析センター 分子医学
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Tsunoda Tatsuhiko
Laboratory for Medical Informatics, Center for Genomic Medicine, RIKEN
-
YAMAMOTO Masahide
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
TADOKORO Kenichi
Development of Clinical Genomics, BML
-
MORITA Yasuyoshi
Department of Hematology, Kinki University School of Medicine
-
KANAMARU Akihisa
Department of Hematology, Kinki University School of Medicine
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
TANIMOTO Mitsune
Blood Transfusion Division, Department of Internal Medicine II, Okayama University Graduate School o
-
KURIYAMA Kazutaka
Blood Immunology Laboratory, School of Health Sciences, Faculty of Medicine and University Hospital,
-
KOBAYASHI Toru
Department of Hematopoietic Pathobiology and Medical Oncology, Mie University Graduate School of Med
-
IMOTO Shion
Hyogo Prefectural Red Cross Blood Center
-
OHNISHI Kazunori
Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
KISHIMOTO Yuji
The First Department of Internal Medicine, Kansai Medical University
-
OKADA Masaya
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
HANDA Hiroshi
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
-
KAGEYAMA Shinichi
Department of Hematology and Oncology, Mie University Graduate School of Medicine
-
MAEDA Yasuhiro
Department of Hematology, Kinki University School of Medicine
-
OHNISHI Kazunori
Oncology Center, Hamamatsu University School of Medicine
-
NAGAFUJI Koji
Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine
-
SAKAMAKI Hisashi
Division of Hematology, Tokyo Metropolitan Komagome Hospital
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
Iida Hiroatsu
Department of Hematology, Meitetsu Hospital
-
ISHIKAWA Yuichi
Department of Pathology, the Cancer Institute of JFCR
-
Yoshida Shirou
Department of Life and Environment Engineering, The University of Kitakyushu
-
Miyazawa Keisuke
Department of Biochemistry and Intractable Immune System Disease Research Center, Tokyo Medical Univ
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学(整形外科)
-
SADAHIRA Yoshito
Department of Pathology, Kawasaki Medical School
-
馬場 秀夫
国立病院機構熊本南病院 外科
-
YOSHIKAWA Hideki
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine
-
Mizuno Kyoichi
Division Of Cardiology Hepatology Geriatrics And Integrated Medicine Department Of Internal Medicine
-
Matsuda Koichi
Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital
-
Mizuno Kyoichi
日本医科大学 内科学
-
SUZUKI Yoshihiko
Suzuki clinic
-
Sakashita Naomi
Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University
-
NAKAO Shinji
Department of Cellular Transplantation Biology, Graduate School of Medical Sciences, Kanazawa Univer
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
Yoshida S
Chiba University
-
MATSUNO Yoshihiro
Department of Surgical Pathology, Hokkaido University Hospital
-
YOKOYAMA Hiroki
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
TAJI Hirofumi
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Hamasaki Makoto
Department of Pathology, Faculty of Medicine, Fukuoka University
-
Nabeshima Kazuki
Department of Pathology, Faculty of Medicine, Fukuoka University
-
Nishimura M
First Department Of Medicine Hokkaido University School Of Medicine
-
Tobinai Kensei
東海大学 医学部
-
HAYASHI Tomayoshi
Department of Pathology, Nagasaki University Hospital of Medicine and Dentistry
-
Saito Y
Division Of Cardiovascular Medicine Kumamoto University Graduate School Of Medical Sciences
-
BABA Hideo
Department of Surgery, Kyushu Cancer Center
-
MIYAZAKI Koji
Departments of Surgery, Saga Medical School
-
Saito Yoshiro
国立医薬品食品衛生研究所
-
SHIKU Hiroshi
Second Department of Internal Medicine, Mie University School of Medicine
-
TOMONAGA Masao
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
Totsune Kazuhito
東北大学 臨床薬学
-
Tokunaga Katsushi
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
MATSUDA Koichi
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, the University
-
Akiba Takashi
Department Of Medicine Kidney Center Tokyo Women's Medical University
-
Nakamura Yusuke
東京大学医科学研究所ヒトゲノム解析センター ゲノムシークエンス解析分野
-
Sakisaka Shotaro
Third Department Of Medicine Fukuoka University School Of Medicine
-
Sakisaka Shotaro
福岡大学 1病理
-
Yokoyama Reiko
Pharmacy Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
NAJIMA Yuho
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
KAWAMURA Machiko
Pediatrics Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
ONOZUKA Yuji
Development of Clinical Genomics
-
UEDA Yasunori
Department of Pediatrics and Department of Hematology/Oncology, Kurashiki Central Hospital
-
INAGAKI Hiroshi
Department of Cardiovascular Medicine, Tokyo Medical and Dental University
-
ASANO Naoko
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center
-
ISHIDA Fumihiro
Department of Internal Medicine, Shinshu University School of Medicine
-
OGAWA Hiroshi
Department of Pathology, Seirei Mikatahara General Hospital
-
Nagane Y
Sanai Hospital Iwate Jpn
-
Nagane Yutaka
東京大学医科学研究所ヒトゲノム解析センター
-
Tsunoda T
Laboratory For Medical Informatics Snp Research Center Riken (institute Of Physical And Chemical Res
-
YOSHIMURA Kenichi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
OKAMOTO Rumiko
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
HIRANO Masami
Department of Hematology, Fujita Health University School of Medicine
-
ASAOKU Hideki
Clinical Laboratory, Hiroshima Red Cross Hospital, Atomic-Bomb Survivors Hospital
-
KUROSAWA Mitsutoshi
Department of Hematology, National Hospital Organization, Hokkaido Cancer Center
-
MAEDA Yoshiharu
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
OMACHI Ken
Department of Hematology and Oncology, Tokai University School of Medicine
-
KASAI Masaharu
Department of Hematology, Sapporo Hokuyu Hospital
-
TAKAYAMA Nobuyuki
Second Department of Internal Medicine, Kyorin University
-
KABA Harumi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
YAMAMOTO Seiichiro
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
FUKUDA Haruhiko
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
HOTTA Tomomitsu
National Hospital Organization, Nagoya Medical Center
-
Baba Hideo
熊本大学 医学薬学研究部消化器外科学
-
HANAMURA Akitoshi
Department of Hematology, Gifu Prefectural Tajimi Hospital
-
Kishimoto Yuji
Kansai Medical University Takii Hospital
-
Koike Minako
東京女子医科大学附属腎臓病総合医療センター
-
HIGASHIHARA Masaaki
Department of Hematology, Kitasato University School of Medicine
著作論文
- Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- PJ-788 Calmodulin Regulates Mitochondrial Ca2+ Homeostasis by Activating Mitochondrial Na+/Ca2+ Exchanger(PJ132,Heart Failure, Basic (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-062 Evaluation of Low- Non- Enhancement Myocardium on Cardiac Multi-Detector Row Computed Tomography (MDCT) in the Diagnosis of Myocardial Viability(PJ011,CT/MRI (Myocardium) 4 (I),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Jap
- OE-133 Thiol-Mediated Responses Contribute to the Biphasic Effects of Nitric Oxide (NO) on Mitochondrial Permeability Transition Pore(OE23,Heart Failure (Pathophysiology) (M),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese C
- FRS-065 Regulation of Mitochondrial Permeability Transition Pore by Glycogen Synthase Kinase 3β (GSK3β) is Related to Mitochondria-bound Hexokinase Activity(FRS13,Novel Molecular Mechanisms of Heart Failure 2 (M),Featured Research Session (English),The 73
- PJ-145 Intravenous Glutathione(GSH), a Novel Prophylaxis against Contrast-induced Nephropathy(CIN)(Kidney/Renal circulation(05)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-115 Protein phosphatase inhibitor 1 (l-1) augments a protein kinase A-dependent increase in SR Ca2+ loading without changing Ca2+ spark(Heart failure, basic(05)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation
- PE-217 Different Effects of Palmitoyl-L-carnitine and Palmitoyl-CoA on Mitochondrial Function in Rat Myocytes(Metabolism/Biochemistry/Energetics(02)(M),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-094 Local Control of Mitochondrial Membrane Potential and Permeability Transition Pore by Calcium and Calmodulin in Rat Ventricular Myocytes(Heart failure, basic(02)(M),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circ
- OJ-051 Dual Effects of Nitric Oxide on Mitochondrial Permeabillity Transition in Rat Ventricular Myocytes(Myocarditis, basic/clinical(M),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
- Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Allergic Reaction Involving Liver Dysfunction and Disseminated Intravascular Coagulation Caused by a Health Food, Proporis
- Follicular lymphoma frequently originates in the salivary gland
- Expression of Apoptosis-Associated Protein RCAS1 in Macrophages of Histiocytic Necrotizing Lymphadenitis
- Gene Expression in Adult T Cell Leukemia/Lymphoma : Up-Regulation of Matrix Metalloproteinase 2 in Skin Lesions
- PJ-566 Influence of CYP2C9 Genotype on Pharmacokinetics and Pharmacodynamics of Benzbromarone(Cardiovascular pharmacology, basic/clinical-6, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-561 Antiproliferative Effect of Cyclic AMP on Human Umbilical Vein Endothelial Cells through TGF-beta Inducing p21(Cip1/Waf1) Expression(Cardiovascular pharmacology, basic/clinical-6, The 71st Annual Scientific Meeting of the Japanese Circulation Socie
- PJ-337 The significance of Delayed Enhancement MRI to Evaluate Global and Local Left Ventricular Wall Function in Hypertrophic Cardiomyopathy(Cardiomyopathy, basic/clinical-5 (M) PJ57,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meetin
- OJ-002 Influence of Genetic Polymorphisms of OATP-C on Cholesterol Lowering Effect of Pravastatin(Cardiovascular pharmacology, basic/clinical-2 (H) OJ1,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- OE-243 Regenerated Endothelium Produces not Vasodilative but Vasoconstrictive Prostanoid(s) via Cyclooxygenase-dependent Pathway(Chronic coronary heart disease/Remodeling(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japane
- Mikulicz's disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
- Acquired Storage-Pool Disorders Occurring Late After Allogeneic Bone Marrow Transplantation: Partial Activation of Platelets in Asymptomatic Patients
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Oncogene Associated cDNA Microarray Analysis Shows PRAME Gene Expression is a Marker for Response to Anthracycline Containing Chemotherapy in Patients with Diffuse Large B-cell Lymphoma
- Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma
- High-grade mature B-cell lymphoma with Burkitt-like morphology : Results of a clinicopathological study of 72 Japanese patients
- Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression
- Follicular lymphoma of the stomach : immunohistochemical and molecular genetic studies
- Primary colorectal T-cell lymphoma
- Rearrangement of immunoglobulin heavy and light chains and VH family in thyroid and salivary gland lymphomas
- Clinicopathological features of gastric B-cell lymphoma: A series of 317 cases
- Peripheral T-cell lymphoma with a nodular growth pattern
- The World Health Organization classification of malignant lymphoma : Incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka
- L-Asparaginase Induced Durable Remission of Relapsed Nasal NK/T-Cell Lymphoma After Autologous Peripheral Blood Stem Cell Transplantation
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Analysis of the Epstein-Barr viral genome in so-called malignant histiocytosis syndrome
- Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
- Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
- Frequent Exacerbation of Pulmonary Nocardiosis during Maintenance Antibiotic Therapies in a Hematopoietic Stem Cell Transplant Recipient
- Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan : A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
- Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation
- Pneumatosis coli after Thalidomide Treatment
- Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
- Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL
- Arrhythmogenic Effects of Arsenic Trioxide in Patients With Acute Promyelocytic Leukemia and an Electrophysiological Study in Isolated Guinea Pig Papillary Muscles
- Basic Fibroblast Growth Factor and Fibrosis in Hodgkin's Disease
- Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome
- Hepatitis B Virus Reactivation in a Patient With Chronic GVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
- Expression profiles of two types of human knee-joint cartilage
- Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation
- Successful Unrelated Bone Marrow Transplantation After Arsenic Trioxide Treatment in a Patient With Relapsed Acute Promyelocytic Leukemia
- Composition of the endophytic filamentous fungi isolated from the tea plant Camellia sinensis
- Bisanthraquinone Metabolites Produced by the Endophytic Fungus Diaporthe sp.
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma
- Erythrocytosis caused by erythropoietin-producing thymic carcinoma
- Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease
- Effect of Additional Chromosomal Abnormalities in Acute Promyelocytic Leukemia Treated With All-trans-Retinoic Acid: A Report of 17 Patients
- Second Allogeneic Peripheral Blood Stem Cell Transplantation With Fludarabine-Based Low-Intensity Conditioning Regimen for Relapsed Myelodysplastic Syndrome After Allogeneic Bone Marrow Transplantation
- Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis
- Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection
- Distribution of malignant lymphoma in Japan : Analysis of 2260 cases, 2001-2006
- Estimation of apoptosis and cell proliferation in histiocytic necrotizing lymphadenitis using immunohistochemical double staining
- Hepatocellular apoptosis associated with cytotoxic T/natural killer-cell infiltration in chronic active EBV infection
- Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas : Analysis of 490 cases
- Macrophages in Langerhans cell histiocytosis are differentiated toward M2 phenotype : Their possible involvement in pathological processes
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Composition of endophytic fungi living in Cinchona ledgeriana (Rubiaceae)
- Artemisioside, a new monoterpene glucoside from the aerial parts of Artemisia ordosica (Asteraceae)
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Benzbromarone Pharmacokinetics and Pharmacodynamics in Different Cytochrome P450 2C9 Genotypes
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
- Brain surface spindle cell glioma in a patient with medically intractable partial epilepsy : A variant of monomorphous angiocentric glioma?
- Regression of rectal mucosa-associated lymphoid tissue (MALT) lymphoma after antibiotic treatments
- Infant juvenile myelomonocytic leukemia (JMML) with rapid infiltration of multiple organs
- Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL)
- Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues
- Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Osteonecrosis of the humeral head
- M2 Macrophage/Microglial Cells Induce Activation of Stat3 in Primary Central Nervous System Lymphoma
- Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study